← back to search

Shajahan Ismail

Palo Alto University · US
Area of research
Psychiatry and Mental health · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Medicine, Placebo, Antidepressant, Schizophrenia (object-oriented programming), Randomized controlled trial, and Myotonic dystrophy.
h-index
—
citations
65
works
2
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

372PIntegrating cognition and neuroimaging: a study of cerebral regions in myotonic dystrophy
Neuromuscular Disorders 2025cited by 0position: middledoi
Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial
Health Technology Assessment 2016cited by 65position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

L. Karman · Palo Alto University1 papers (2025–2025)Mike Crawford · Case Western Reserve University1 papers (2016–2016)— · 1 papers (2016–2016)— · 1 papers (2016–2016)N. Hageman · Palo Alto University1 papers (2025–2025)Thomas R. E. Barnes · Institute for Health Metrics and Evaluation1 papers (2016–2016)David Osborn · University of London1 papers (2016–2016)— · 1 papers (2016–2016)— · 1 papers (2016–2016)John Day · Pediatrics and Genetics1 papers (2025–2025)T. Duong · Palo Alto University1 papers (2025–2025)Glyn Lewis · The London College1 papers (2016–2016)Céire Costelloe · University of London1 papers (2016–2016)J. Sampson · Palo Alto University1 papers (2025–2025)Tom Craig · University of London1 papers (2016–2016)John Geddes · University of Oxford1 papers (2016–2016)Judit Simon · Johannes Gutenberg University Mainz1 papers (2016–2016)— · 1 papers (2016–2016)Mark A. Rogers · Palo Alto University1 papers (2025–2025)— · 1 papers (2016–2016)